0.18 USD
↘ 0.00 (1.79%)PRE MARKET (AS OF 08:49 AM EST)
Shares of Vistagen Therapeutics, Inc. Common Stock (VTGN) are trading at $0.18. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, VTGN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.